Gyros Protein Technologies and Cygnus Technologies Sign Licensing and Supply Agreement

12-Jul-2018 - Gyros Protein Technologies AB and Cygnus Technologies announced they have signed a licensing and supply agreement. Under the agreement, Cygnus Technologies will supply Gyros Protein Technologies with its proprietary reagents for host cell protein analysis, enabling the development of new Gyrolab® ...

Gyros Protein Technologies appoints Mark Vossenaar as Vice President, European Sales

08-May-2017 - Gyros Protein Technologies AB announced the appointment of Mark Vossenaar as Vice President Sales, Europe, effective immediately. Mr Vossenaar brings more than 25 years of experience in developing and leadinglife and health science commercial teams, having worked for large and small companies ...

Gyros Protein Technologies appoints Gerrit van den Dool to Board of Directors

20-Jan-2017 - Gyros Protein Technologies AB, a pioneer in automated nanoliter-scale immunoassays and leading provider of peptide synthesizers and reagents, announced today the appointment of Gerrit van den Dool to its Board of Directors, as a Non-Executive Director. With more than 25 years’ experience in the ...

Gyros AB Quality Management System receives ISO 9001:2008 certification

21-Dec-2012 - Gyros AB announced its quality management system has received ISO 9001:2008 certification. The Gyros platform is used by biopharmaceutical companies and their service providersto improve productivity and efficiency during the development of biotherapeutics and vaccines, boosting time-critical ...

Gyros Expands Asian Distribution to Singapore

11-Jun-2012 - Gyros AB announced that Bio Laboratories Pte Ltd has become sole distributor for the company’s nanoliter-scale immunoassay platform in Singapore. “We are very pleased to expand our reach in Asia through this new partnership with Bio Laboratories, which provides a valuable addition to our recently ...

Gyros announces changes to its management team

Dr. Jon-Sverre Schanche becomes Chief Technology Officer and Vice President Technical Affairs

25-Oct-2011 - Gyros AB announced the appointment of Dr. Jon-Sverre Schanche as Chief Technology Officer and Vice President Technical Affairs. Dr. Schanche’s appointment comes as Nils Kristensen, COO and VP Technical Operations, and Stephan Hoffmann, VP Business Development, leave the company.Dr. Schanche has ...

Gyros and GE Healthcare Life Sciences expand Asian distribution relationship to China, Taiwan and Hong Kong

30-Aug-2011 - Gyros AB announced that GE Healthcare Life Sciences has become sole distributor for the company’s nanoliter-scale immunoassay platform in China, Taiwan and Hong Kong. The Gyros platform is used by major biopharmaceutical companies and their service providers to improve productivity and efficiency ...

Gyros Completes Next Stage of Development Program with Expansion of Product Portfolio

05-Aug-2011 - Gyros AB announced the completion of a development program initiated to fulfill the requirements of scientists using the Company’s immunoassay platform in the biopharmaceutical industry. The development program has seen the release of a number of software modules and services to augment the ...

Gyros wins SwedenBIO Award 2011

30-May-2011 - Gyros AB announced its selection as the 2011 winner of the SwedenBIO award. The award scheme, now in its fifth year, focuses attention on Swedish life science companies or industry leaders that have achieved significant national and international recognition during the previous year.Commenting on ...

Gyros and SCRUM sign distribution agreement for the Japanese market

24-Feb-2010 - Gyros® AB announced the signing of an exclusive distribution agreement with SCRUM Inc. Under the terms of the agreement, SCRUM will market, sell and fully support the Gyros product range, within the Japanese biopharmaceutical, contract research and contract manufacturing industries. "We are very ...